1. Home
  2. INSP vs EVO Comparison

INSP vs EVO Comparison

Compare INSP & EVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Inspire Medical Systems Inc.

INSP

Inspire Medical Systems Inc.

HOLD

Current Price

$60.09

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Logo Evotec SE

EVO

Evotec SE

HOLD

Current Price

$1.98

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
INSP
EVO
Founded
2007
1993
Country
United States
Germany
Employees
N/A
4553
Industry
Medical/Dental Instruments
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.0B
IPO Year
2018
N/A

Fundamental Metrics

Financial Performance
Metric
INSP
EVO
Price
$60.09
$1.98
Analyst Decision
Buy
Strong Buy
Analyst Count
16
1
Target Price
$94.00
$7.00
AVG Volume (30 Days)
890.2K
50.7K
Earning Date
05-04-2026
04-08-2026
Dividend Yield
N/A
N/A
EPS Growth
179.43
N/A
EPS
N/A
N/A
Revenue
$82,050,000.00
N/A
Revenue This Year
$8.02
$1.37
Revenue Next Year
$8.11
$10.05
P/E Ratio
N/A
N/A
Revenue Growth
62.18
N/A
52 Week Low
$38.91
$1.90
52 Week High
$147.03
$4.27

Technical Indicators

Market Signals
Indicator
INSP
EVO
Relative Strength Index (RSI) 66.87 32.32
Support Level $57.57 N/A
Resistance Level $86.00 $3.84
Average True Range (ATR) 2.61 0.05
MACD 0.83 0.02
Stochastic Oscillator 67.46 40.54

Price Performance

Historical Comparison
INSP
EVO

About INSP Inspire Medical Systems Inc.

Inspire Medical Systems Inc operates as a medical technology company. It focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The firm has operating footprints in the United States and All other countries wherein, it generates a majority of its revenue from the United States. Its segment revenues are derived from the sales of its product, the Inspire system, to hospitals and ambulatory surgery centers in the U.S. and in selected countries in Europe and the Asia Pacific region.

About EVO Evotec SE

Evotec SE is a life science company focused on developing pharmaceutical products through standalone services, integrated R&D programs, and strategic partnerships with pharmaceutical and biotechnology companies, academic institutions, and other partners. It operates across drug discovery, preclinical development, and manufacturing, with expertise in areas including oncology, central nervous system, cardiovascular-renal, immune and inflammatory, infectious, and other diseases. The Company generates revenue through fee-for-service and FTE-based services, milestones, and royalties, and equity ownership in biotechnology and academic projects. It operates through the Shared R&D and Discovery & Preclinical Development (D&PD) segments, with the majority of revenue generated from the USA.

Share on Social Networks: